A Phase II Study of Belotecan (CKD-602) in Recurrent or Progressive Carcinoma of Uterine Cervix.
Phase of Trial: Phase II
Latest Information Update: 25 Apr 2012
At a glance
- Drugs Belotecan (Primary)
- Indications Uterine cancer
- Focus Therapeutic Use
- 25 Apr 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 25 Apr 2012 Actual end date (Oct 2010) added as reported by ClinicalTrials.gov.
- 25 Apr 2012 Actual patients number is 16 as reported by ClinicalTrials.gov.